Clinical Trial Update: Evaluation of the Efficacy and Safety of Fentanyl Delivered by Adhesive Skin Patch in Out-Patients With Chronic Cancer Pain [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of a fentanyl transdermal patch for chronic cancer pain was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Pain

Drugs mentioned

• Duragesic (fentanyl transdermal system)

Snippet

Sponsor: Janssen Cilag S.A.S. | Conditions: Pain | Phase 4 | Status: TERMINATED